Pharmaceutical composition and use thereof
AssigneeAlphala Co., Ltd & Chung-Chin Chen
InventorsChi-Jen HONG, Yen-Fu CHEN, Cheng-Ho CHUNG
Life of this patent
Estimating the term…
Abstract
Disclosed is a pharmaceutical composition comprising: an active ingredient of the following formula (I) or a pharmaceutically acceptable salt or solvate thereof present in an amount of 8 wt % to 30 wt %: and two or more excipients at least including a dispersant and a solubilizer present in an amount of 70 wt % to 92 wt %. Also disclosed are methods for reducing the glycemic level and treating disorders associated with glucagon with the aforesaid pharmaceutical composition.
Claims20
A pharmaceutical composition, comprising:
- an active ingredient of the following formula (I) or a pharmaceutically acceptable salt or solvate thereof present in an amount of 8 wt % to 30 wt %:
- two or more excipients at least including a dispersant and a solubilizer present in an amount of 70 wt % to 92 wt %.
A method for reducing the glycemic level in a subject, comprising administering to the subject in need thereof a pharmaceutical composition, wherein the pharmaceutical composition comprises:
- an active ingredient of the following formula (I) or a pharmaceutically acceptable salt or solvate thereof present in an amount of 8 wt % to 30 wt %:
- and
- two or more excipients at least including a dispersant and a solubilizer preset in an amount of 70 wt % to 92 wt %.
A method of treating disorders associated with glucagon, comprising administering to a subject in need thereof a pharmaceutical composition, wherein the pharmaceutical composition comprises:
- an active ingredient of the following formula (I) or a pharmaceutically acceptable salt or solvate thereof present in an amount of 8 wt % to 30 wt %:
- and
- two or more excipients at least including a dispersant and a solubilizer present in an amount of 70 wt % to 92 wt %.
Dependencies are inferred from the claim text.